Evidence map›Paper›PMID 33375091›Full record

ArticleMolecules (Basel, Switzerland)2020

Anti-Platelet Aggregation and Anti-Cyclooxygenase Activities for a Range of Coffee Extracts (

Nuntouchaporn Hutachok, Pongsak Angkasith, Chaiwat Chumpun, Suthat Fucharoen, Ian J Mackie, John B Porter, Somdet Srichairatanakool

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. UHPLC-QTOF-MS Profiling of Chemical Constituents in POW9International journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Genome Characterization ofFoods (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Nuntouchaporn HutachokDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-3856-5309
Pongsak AngkasithRoyal Project Foundation, Chiang Mai 50200, Thailand.
Chaiwat ChumpunRoyal Project Foundation, Chiang Mai 50200, Thailand.
Suthat FucharoenThalassemia Research Center, Institute of Molecular Biosciences, Mahidol University Salaya Campus, Nakornpathom 71300, Thailand.
Ian J MackieHaemostasis Research Unit, Department of Haematology, University College London Medical School, London WC1E 6BT, UK.
John B PorterRed Cell Disorder Unit, Department of Haematology, University College London Medical School, London WC1E 6BT, UK.
Somdet SrichairatanakoolDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-5706-8781
Chiang Mai University · THRoyal Project Foundation · THUniversity College London · GBMahidol University · TH

Funding

Medical Faculty Endowment Fund, Faculty of Medicine, Chiang Mai University 113/2563Research and Researchers for Industries (RRI) PhD. Program, Thailand Science Research and Innovation (formerly Thailand Research Fund) PHD60I0020Royal Project Foundation, Chiang Mai PHD60I0020
6 · The paper itself

Abstract

Coffee is rich in caffeine (CF), chlorogenic acid (CGA) and phenolics. Differing types of coffee beverages and brewing procedures may result in differences in total phenolic contents (TPC) and biological activities. Inflammation and increases of platelet activation and aggregation can lead to thrombosis. We focused on determining the chemical composition, antioxidant activity and inhibitory effects on agonist-induced platelet aggregation and cyclooxygenase (COX) of coffee beverages in relation to their preparation method. We prepared instant coffee and brewed coffee beverages using drip, espresso, and boiling techniques. Coffee extracts were assayed for their CF and CGA contents using HPLC, TPC using colorimetry, platelet aggregation with an aggregometer, and COX activity using ELISA. The findings have shown all coffee extracts, except the decaffeinated types, contained nearly equal amounts of CF, CGA, and TPC. Inhibitory effects of coffee extracts on platelet aggregation differed depending on the activation pathways induced by different agonists. All espresso, drip and boiled coffee extracts caused dose dependent inhibition of platelet aggregation induced by ADP, collagen, epinephrine, and arachidonic acid (ARA). The most marked inhibition was seen at low doses of collagen or ARA. Espresso and drip extracts inhibited collagen-induced platelet aggregation more than purified caffeine or CGA. Espresso, boiled and drip coffee extracts were also a more potent inhibitors of COX-1 and COX-2 than purified caffeine or CGA. We conclude that inhibition of platelet aggregation and COX-1 and COX-2 may contribute to anti-platelet and anti-inflammatory effects of espresso and drip coffee extracts.

Indexed as

Chlorogenic AcidChromatography, High Pressure LiquidCoffeaCoffeeCyclooxygenase InhibitorsMolecular StructurePlant ExtractsPlatelet AggregationPlatelet Aggregation InhibitorsChlorogenic AcidCoffeeCyclooxygenase InhibitorsPlant ExtractsPlatelet Aggregation Inhibitorschlorogenic acidcoffeecyclooxygenaseespressoinstant coffeeplatelet aggregation

Identifiers

PMID33375091
PMCPMC7792775
OpenAlexW3109412245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.